Cargando…

An analysis of the immunological tumor microenvironment of primary tumors and regional lymph nodes in squamous cell lung cancer

BACKGROUND: Various immune cells that play a central role in antitumor immunity accumulate in primary tumors and regional lymph nodes. Such cellular accumulation and the molecular expression were analyzed to elucidate the immunological tumor microenvironment. METHODS: Fifty squamous cell lung cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Ichiki, Yoshinobu, Ueno, Mari, Yanagi, Shinya, Kanasaki, Yoshiro, Goto, Hidenori, Fukuyama, Takashi, Mikami, Shuji, Nakanishi, Kozo, Ishida, Tsuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435388/
https://www.ncbi.nlm.nih.gov/pubmed/34584854
http://dx.doi.org/10.21037/tlcr-21-479
_version_ 1783751781586567168
author Ichiki, Yoshinobu
Ueno, Mari
Yanagi, Shinya
Kanasaki, Yoshiro
Goto, Hidenori
Fukuyama, Takashi
Mikami, Shuji
Nakanishi, Kozo
Ishida, Tsuyoshi
author_facet Ichiki, Yoshinobu
Ueno, Mari
Yanagi, Shinya
Kanasaki, Yoshiro
Goto, Hidenori
Fukuyama, Takashi
Mikami, Shuji
Nakanishi, Kozo
Ishida, Tsuyoshi
author_sort Ichiki, Yoshinobu
collection PubMed
description BACKGROUND: Various immune cells that play a central role in antitumor immunity accumulate in primary tumors and regional lymph nodes. Such cellular accumulation and the molecular expression were analyzed to elucidate the immunological tumor microenvironment. METHODS: Fifty squamous cell lung cancer patients with complete resection were included. Resected specimens from primary lung tumors and regional lymph nodes were immunostained for immune-related molecules, such as CD8, CD103, major histocompatibility complex (MHC) class I, and programmed cell death protein ligand-1 (PD-L1), and the relationship between the prognosis and clinicopathological factors was retrospectively analyzed. RESULTS: Tumor-infiltrating lymphocytes and CD8+ lymphocytes, intratumoral and intrastromal CD103+ lymphocytes, tumor diameter, pathological T and N factors, and pathological stage were significant prognostic factors for the disease-specific survival (DSS) in a univariate analysis. In a multivariate analysis, intratumoral and intrastromal CD103+ lymphocytes and pathological T and N factors were independent prognostic factors of the DSS. Significant concordance was found between the PD-L1 expression of primary tumors and metastatic lymph nodes as well as among tumor-infiltrating lymphocytes, CD8+ lymphocytes and CD103+ lymphocytes. Infiltration of CD103+ lymphocytes into the tumor was significantly correlated with an increased PD-L1 expression of cancer cells in both primary tumors and reginal lymph node metastases. Both the intratumoral infiltration of CD103+ lymphocytes and PD-L1 expression of cancer cells were significantly higher in lymph node metastases than in primary tumors. CONCLUSIONS: CD103+ lymphocyte infiltration in the primary tumor was shown to be strongly involved in the prognosis.
format Online
Article
Text
id pubmed-8435388
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-84353882021-09-27 An analysis of the immunological tumor microenvironment of primary tumors and regional lymph nodes in squamous cell lung cancer Ichiki, Yoshinobu Ueno, Mari Yanagi, Shinya Kanasaki, Yoshiro Goto, Hidenori Fukuyama, Takashi Mikami, Shuji Nakanishi, Kozo Ishida, Tsuyoshi Transl Lung Cancer Res Original Article BACKGROUND: Various immune cells that play a central role in antitumor immunity accumulate in primary tumors and regional lymph nodes. Such cellular accumulation and the molecular expression were analyzed to elucidate the immunological tumor microenvironment. METHODS: Fifty squamous cell lung cancer patients with complete resection were included. Resected specimens from primary lung tumors and regional lymph nodes were immunostained for immune-related molecules, such as CD8, CD103, major histocompatibility complex (MHC) class I, and programmed cell death protein ligand-1 (PD-L1), and the relationship between the prognosis and clinicopathological factors was retrospectively analyzed. RESULTS: Tumor-infiltrating lymphocytes and CD8+ lymphocytes, intratumoral and intrastromal CD103+ lymphocytes, tumor diameter, pathological T and N factors, and pathological stage were significant prognostic factors for the disease-specific survival (DSS) in a univariate analysis. In a multivariate analysis, intratumoral and intrastromal CD103+ lymphocytes and pathological T and N factors were independent prognostic factors of the DSS. Significant concordance was found between the PD-L1 expression of primary tumors and metastatic lymph nodes as well as among tumor-infiltrating lymphocytes, CD8+ lymphocytes and CD103+ lymphocytes. Infiltration of CD103+ lymphocytes into the tumor was significantly correlated with an increased PD-L1 expression of cancer cells in both primary tumors and reginal lymph node metastases. Both the intratumoral infiltration of CD103+ lymphocytes and PD-L1 expression of cancer cells were significantly higher in lymph node metastases than in primary tumors. CONCLUSIONS: CD103+ lymphocyte infiltration in the primary tumor was shown to be strongly involved in the prognosis. AME Publishing Company 2021-08 /pmc/articles/PMC8435388/ /pubmed/34584854 http://dx.doi.org/10.21037/tlcr-21-479 Text en 2021 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Ichiki, Yoshinobu
Ueno, Mari
Yanagi, Shinya
Kanasaki, Yoshiro
Goto, Hidenori
Fukuyama, Takashi
Mikami, Shuji
Nakanishi, Kozo
Ishida, Tsuyoshi
An analysis of the immunological tumor microenvironment of primary tumors and regional lymph nodes in squamous cell lung cancer
title An analysis of the immunological tumor microenvironment of primary tumors and regional lymph nodes in squamous cell lung cancer
title_full An analysis of the immunological tumor microenvironment of primary tumors and regional lymph nodes in squamous cell lung cancer
title_fullStr An analysis of the immunological tumor microenvironment of primary tumors and regional lymph nodes in squamous cell lung cancer
title_full_unstemmed An analysis of the immunological tumor microenvironment of primary tumors and regional lymph nodes in squamous cell lung cancer
title_short An analysis of the immunological tumor microenvironment of primary tumors and regional lymph nodes in squamous cell lung cancer
title_sort analysis of the immunological tumor microenvironment of primary tumors and regional lymph nodes in squamous cell lung cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435388/
https://www.ncbi.nlm.nih.gov/pubmed/34584854
http://dx.doi.org/10.21037/tlcr-21-479
work_keys_str_mv AT ichikiyoshinobu ananalysisoftheimmunologicaltumormicroenvironmentofprimarytumorsandregionallymphnodesinsquamouscelllungcancer
AT uenomari ananalysisoftheimmunologicaltumormicroenvironmentofprimarytumorsandregionallymphnodesinsquamouscelllungcancer
AT yanagishinya ananalysisoftheimmunologicaltumormicroenvironmentofprimarytumorsandregionallymphnodesinsquamouscelllungcancer
AT kanasakiyoshiro ananalysisoftheimmunologicaltumormicroenvironmentofprimarytumorsandregionallymphnodesinsquamouscelllungcancer
AT gotohidenori ananalysisoftheimmunologicaltumormicroenvironmentofprimarytumorsandregionallymphnodesinsquamouscelllungcancer
AT fukuyamatakashi ananalysisoftheimmunologicaltumormicroenvironmentofprimarytumorsandregionallymphnodesinsquamouscelllungcancer
AT mikamishuji ananalysisoftheimmunologicaltumormicroenvironmentofprimarytumorsandregionallymphnodesinsquamouscelllungcancer
AT nakanishikozo ananalysisoftheimmunologicaltumormicroenvironmentofprimarytumorsandregionallymphnodesinsquamouscelllungcancer
AT ishidatsuyoshi ananalysisoftheimmunologicaltumormicroenvironmentofprimarytumorsandregionallymphnodesinsquamouscelllungcancer
AT ichikiyoshinobu analysisoftheimmunologicaltumormicroenvironmentofprimarytumorsandregionallymphnodesinsquamouscelllungcancer
AT uenomari analysisoftheimmunologicaltumormicroenvironmentofprimarytumorsandregionallymphnodesinsquamouscelllungcancer
AT yanagishinya analysisoftheimmunologicaltumormicroenvironmentofprimarytumorsandregionallymphnodesinsquamouscelllungcancer
AT kanasakiyoshiro analysisoftheimmunologicaltumormicroenvironmentofprimarytumorsandregionallymphnodesinsquamouscelllungcancer
AT gotohidenori analysisoftheimmunologicaltumormicroenvironmentofprimarytumorsandregionallymphnodesinsquamouscelllungcancer
AT fukuyamatakashi analysisoftheimmunologicaltumormicroenvironmentofprimarytumorsandregionallymphnodesinsquamouscelllungcancer
AT mikamishuji analysisoftheimmunologicaltumormicroenvironmentofprimarytumorsandregionallymphnodesinsquamouscelllungcancer
AT nakanishikozo analysisoftheimmunologicaltumormicroenvironmentofprimarytumorsandregionallymphnodesinsquamouscelllungcancer
AT ishidatsuyoshi analysisoftheimmunologicaltumormicroenvironmentofprimarytumorsandregionallymphnodesinsquamouscelllungcancer